Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

isotretinoin

A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:13-cis-retinoic acid
13-cis-vitamin A acid
cis-retinoic acid
isotretinoinum
neovitamin A
Neovitamin A Acid
US brand name:Accutane
Amnesteem
Cistane
Claravis
Sotret
Foreign brand name:Accure
Isotrex
Isotrexin
Oratane
Roaccutan
Roaccutane
Roacutan
Abbreviation:13-CRA
Code name:Ro 4-3780
Chemical structure:3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)2cis-4-trans-6-trans-8-trans-nonatetraenoic Acid
IND number:28104
NSC code:329481
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search